Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

ABSTRACT: Exome capture of pooled population samples of Pinus sibirica

PROVIDER: PRJNA506885 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR8241524_1.fastq.gz	Fastqsanger.gz
	SRR8241524_2.fastq.gz	Fastqsanger.gz
	SRR8241525_1.fastq.gz	Fastqsanger.gz
	SRR8241525_2.fastq.gz	Fastqsanger.gz
	SRR8241526_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 6

Similar Datasets

PiCadapt

Project description:Exome capture of pooled population samples of Pinus cembra (Swiss stone pine)

| PRJEB37935 | ENA

Project description:Exome capture of pooled population samples of Pinus Cembra (Swiss stone pine)

| PRJNA506527 | ENA

Exome capture of pooled population samples of Pinus cembra (Swiss stone pine)

Project description:Exome capture of pooled population samples of Pinus cembra (Swiss stone pine)

| PRJEB41735 | ENA

Pinus sibirica

Project description:Pinus sibirica overview

| PRJNA684655 | ENA

Pinus pinaster

Project description:GenTree Pinus pinaster Exome capture

| PRJNA602468 | ENA

Pinus sylvestris

Project description:GenTree Pinus sylvestris Exome capture

| PRJNA602473 | ENA

Whole-exome sequencing (WES) of single glands from opposite side of two colorectal tumors and WES of colorectal cancer xenografts derived from single cell culture to study tumor growth dynamics

Project description:Single Gland Whole-exome sequencing: building on our prior description of multi-region WES of colorectal tumors and targeted single gland sequencing (E-MTAB-2247), we performed WES of multiple single glands from different sides (right: A and left: B) of two tumors in this study (tumor O and U) on the illumina platform using the Agilent SureSelect 2.0 or illumina Nextera Rapid Capture Exome kit (SureSelect or NRCE, as indicated in the naming of fastq files). Colorectal Cancer Xenograft Whole-exome sequencing: The HCT116 and LoVo Mismatch-Repair-deficient colorectal adenocarcinoma cell lines were obtained from the ATCC and cultured under standard conditions. For both cell lines, a single âfoundingâ cell was cloned and expanded in vitro to ~6M cells. Two aliquots of ~1M cells were subcutaneously injected into opposite flanks (right and left) of a nude mouse and tumors allowed to reach a size of ~1B cells (1cm3) before the animal was sacrificed. Tumor tissue was collected separately from the right and left lesions and DNA was extracted for WES using the illumina TruSeq Exome kit or Nextera Rapid Capture Exome expanded Kits (Truseq or NRCEe), as was DNA from the first passage population (a polyclonal tissue culture for HCT116 and a polyclonal xenograft sample for LoVo), which were employed as a control to study mutation accumulation in culture and post xenotransplantation.

2017-05-01 | E-MTAB-5547 | biostudies-arrayexpress

Comparison of poly(A) and capture RNA-seq: controlled degradation in vitro

Project description:We compare the performance of two library preparation protocols (poly(A) and exome capture) in in vitro degraded RNA samples

2015-08-03 | GSE64113 | GEO

Project description:Exome capture optimization of Pinus sylvestris

| PRJNA1145653 | ENA

Investigating the altered brain metastatic transcriptome in breast cancer

Project description:Brain metastatic disease occurs in 10-30% of metastatic breast cancer cases. The incidence of brain metastases is increasing with median overall survival < 2 years for patients. In order to better characterize oncogenic pathway activity pertinent to breast cancer brain metastasis, exome capture RNA sequencing was carried out on patient matched primary breast with brain metastatic tumor samples for 45 cases of breast cancer brain metastasis (N= 90 samples). Here, exome capture RNA sequencing data is deposited as sequencing batch corrected log2 transformed trimmed M of means (TMM) normalized counts per million (CPM) (log2(TMM-CPM +1) gene expression values (n=16,714 protein coding genes; N=90 tumor samples).

2022-04-01 | GSE173661 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data